Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

MiddleBrook Aims To Address $600 Million Strep Market With Moxatag

Mar 05 2008

• By Brooke McManus

Related Content

Advancis Likely To Change Name Following Ruling In Favor Of Sanofi-Aventis

Sep 28 2006

Advancis Gets “Refuse To File” Letter For Pulsatile Amoxicillin NDA

Feb 14 2007

Advancis Gets Second Chance On Pulsatile Amoxicillin NDA

Feb 28 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window